Effects of Prior Induced Termination of Pregnancy on Complications and Pregnancy Outcomes.

Reproductive Health Clinical Trial

Official title:

Effects of Prior Induced Termination of Pregnancy on Complications and Pregnancy Outcomes.

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04183829
• Other study ID #: No.2018-I2M-1-004
• Status: Recruiting
• Start date: June 1, 2019
• Est. completion date: June 2022

Study information

• Verified date: June 2019
• Source: National Research Institute for Family Planning, China
• Contact: Tu Pengcheng, M.D.
• Phone: +86 18810266933
• Email: manutu[@]126.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

A prospective multicenter cohort study to evaluate effects of prior induced termination of pregnancy on complications and pregnancy outcomes.

Description:

A prospective multicenter cohort study to evaluate effects of prior induced termination of pregnancy on complications and pregnancy outcomes.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 20000
• Est. completion date: June 2022
• Est. primary completion date: June 2020
• Gender: Female
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria:

• women have induced abortion in early pregnancy (<12 weeks of gestation).

• permanent population and no tendency to move.

• normal language expression and understanding ability, able to understand research content.

• be able and willing to provide written informed consent and effective contact information, and be willing to cooperate with follow-up investigations.

Exclusion Criteria:

• above the age of 40

• with history of adverse pregnancy and childbirth

Related Conditions & MeSH terms

• Reproductive Health

Intervention

Procedure:
• induced termination of pregnancy
Medically, induced termination of pregnancy (I-TOP) is defined as an intervention to voluntarily terminate a pregnancy (ie, induced abortion) by either surgical or medical means so it does not result in a live birth.

Locations

Country	Name	City	State
China	Changzhou Maternal and Child Health Hospital	Changzhou	Jiangsu
China	Daqing People's Hospital	Daqing	Heilongjiang
China	People's Hospital of Inner Mongolia Autonomous Region	Hohhot	Mongolia Autonomous
China	Qingdao Maternal and Child Health Hospital	Qingdao	Shandong
China	Taiyuan Maternal and Child Health Hospital	Taiyuan	Shanxi
China	Tanggu Maternal and Child Health Hospital	Tanggu	Tianjin
China	Yangzhou Maternal and Child Health Hospital	Yangzhou	Jiangsu
China	Zaozhuang Maternal and Child Health Hospital	Zaozhuang	Shandong
China	Zhangjiakou Maternal and Child Health Hospital	Zhangjiakou	Hebei
China	Zhongshan Boai Hospital	Zhongshan	Guangdong

Sponsors (1)

Lead Sponsor	Collaborator
National Research Institute for Family Planning, China

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	adverse pregnancy outcomes	the rate of different adverse pregnancy outcomes	2021.6
Secondary	Complications	the rate of different complications	2020.6